Vaccines
RSSArticles
-
Texas Judge Tosses Suit Over COVID-19 Vaccine Mandate
Plaintiffs expected to challenge ruling in ongoing saga over Houston facility’s policy. -
The Cost-Effectiveness of HPV Vaccination for Adults Age 30 to 45 Years
Researchers found extending the upper limit of HPV vaccination to age 30 to 45 years is not cost-effective. -
FDA, CDC Back COVID-19 Vaccine for Adolescents
The Pfizer/BioNTech solution will be available for Americans age 12 to 15 years. -
Controversy Developing Over Vaccine Passports
Concerns are emerging about individual rights, equal access, and how anyone would enforce mandates.
-
U.S. Supports Waiving Intellectual Property Protections for COVID-19 Vaccines
The aim is to accelerate the spread of shots around the globe.
-
White Adults, Women Overrepresented in U.S. Vaccine Trials
Investigators uncover reporting gaps, lack of proper representation for older adults, minority groups.
-
Herpes Zoster Vaccine: Effective but Underused
The adjuvanted recombinant herpes zoster vaccine is highly effective in practice, but it is vastly underused.
-
AstraZeneca Reports 79% Efficacy for U.S. COVID-19 Vaccine Candidate
But NIH raises questions the about data.
-
The COVID-19 Vaccine Quarantine: A New Staffing Headache
Patient access department employees have been receiving the COVID-19 vaccine. To avoid staffing shortfalls, leaders have been staggering shifts in case anyone who has received the vaccine experiences side effects that would keep them out of work.
-
FDA, CDC Sign Off on Third COVID-19 Vaccine
Johnson & Johnson’s COVID-19 vaccine is the first single-shot solution to receive an agency emergency use authorization.